Journal articleImmunother Adv2026
Growth factor supportive care for chemotherapy-induced neutropenia suppresses antitumour immunity in checkpoint blockade-responsive pancreatic cancer.
- Journal
- Immunother Adv
- Published
- 15 July 2026
- Citations
- 0
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try
Grants 4
- Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma P50CA127003↗
- Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer R01CA276268↗
- Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens U01CA224146↗
- Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity U01CA274276↗